What We Do

We are a new type of pharmaceutical company dedicated to creating affordable, life-changing medicines for serious and life-limiting diseases and medical conditions

Pipeline

ZBP has an active pipeline of products in various stages of development
 
Therapeutic Area
Formulation
Research & Discovery
Regulatory & Review
Expected Commercialization

Diabetes

Short Acting

(RHI)

Type1, Type 2
IV, Pen, Pump

Rapid Acting

Glulisine

Type1, Type 2
IV, Pen, Pump

Intermediate Acting

(NPH)

Type1, Type 2
IV, Pen, Pump

Long Acting

Glargine

Type1, Type 2
IV, Pen, Pump

Combination

70/30

Type1, Type 2
IV, Pen, Pump

GLP - 1

Type1, Type 2
IV, Pen, Pump

Manufacturing

At ZBP, we build our products to the highest quality standards on state-of-the-art automated manufacturing lines because we know that when it comes to potentially life-saving products you expect the very best.

Development & Regulatory

Our team has decades of experience in both U.S. and global regulatory filings. ZBP’s development process includes several rigorous studies, which involve feedback from patients and other stakeholders. This sets us apart; the knowledge and insights gained from listening to our users becomes core part of our submissions.  We conduct our clinical studies under the most stringent of regulatory requirements.

Commercialization

Our commercial team has over 50 years of experience bringing valuable therapies to patients. ZBP commercializes its products through two models:

1. Commercialize products ourselves in specific therapeutic areas.
2. License our products to commercial partners who have the resources and capabilities for our products to reach their potential.
Back to Top of Page